乳腺微创系统在早期乳腺癌诊断中的临床应用分析  

Clinical analysis of Mammotome Biopsy System in early diagnosis of breast cancer

作　　者：吴罗武 WU Luowu(The Second Section of Ninth Department of Surgery,the Fourth People＇ s Hospital of Zhanjiang City, Zhanjiang 524002,Chin)

机构地区：[1]广东省湛江市第四人民医院外九科二区,广东湛江524002

出　　处：《中国医药科学》2017年第22期201-203,共3页China Medicine And Pharmacy

摘　　要：目的探讨乳腺微创系统在早期乳腺癌诊断中的临床应用。方法回顾性分析2015年1月~2016年12月我院收治的124例触诊阴性乳腺病灶(183个病灶)患者。其中86例(128个病灶)为A组,行超声引导下麦默通旋切活检术;38例(55个病灶)为B组,行Bard穿刺活检。比较麦默通旋切活检术和Bard穿刺活检的成功率、准确性和并发症发生情况。结果 A组活检成功率显著高于B组,差异有统计学意义(P<0.05);A组活检准确率显著高于B组,差异有统计学意义(P<0.05);A组的总并发症率显著低于B组,差异有统计学意义(P<0.05)。结论乳腺微创系统在乳腺癌的早期诊断中有成功率高、准确性强、并发症少等诸多优点,值得推广和研究。Objective To explore the use of Mammotome Biopsy System in early diagnosis of breast cancer. Methods A retrospective analysis was carried out on the clinical data of 124 patients with nonpalpable breast lesions（183 lesions） from January 2015 to December 2016 in our hospital.Among them,86 cases （128 lesions） in group A and were performed by Mammotome Biopsy System guided by ultrasound,38 cases （55 lesions） in group B were performed by Bard biopsy.The success ratios, accuracies and complications of group A and group B were compared. Results The biopsy success rate of group A was significantly higher than that of group B, and the difference was statistically significant （P 〈 0.05）.The biopsy accuracy of group A was significantly higher than that of group B, and the difference was statistically significant （P 〈 0.05）.The total complication rate of group A was significantly lower than group B,and the difference was statistically significant （P 〈 0.05）. Conclusion In the early diagnosis of breast cancer,the Mammotome minimally Biopsy System has many advantages,such as high success rate,high accuracy and low complication,which is worth promoting and studying.

关 键 词：乳腺微创系统 早期诊断 触诊阴性乳腺病灶 Bard穿刺活检 

分 类 号：R737.9[医药卫生—肿瘤]